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After permeabilization with the pore-forming toxin streptolysin-O mast cells can be triggered to
secrete by addition of both calcium and a GTP analogue. If stimulation is delayed after perme-
abilization, there is a progressive decrease in the extent of secretion upon stimulation, eventually
leading to a complete loss of the secretory response. This loss of secretory response can be
retarded by the addition of cytosol from other secretory tissues, demonstrating that the response
is dependent on a number of cytosolic proteins. We have used this as the basis of a bioassay to
purify Secernin 1, a novel 50-kDa cytosolic protein that appears to be involved in the regulation
of exocytosis from peritoneal mast cells. Secernin 1 increases both the extent of secretion and
increases the sensitivity of mast cells to stimulation with calcium.
INTRODUCTION
Mast cells are secretory cells found on the mucosal and
serosal surfaces of tissues throughout the body where they
are involved in the allergic response (Wedemeyer and Galli,
2000). The cells can be activated by the cross-linking of
high-affinity IgE receptors by antigen-specific IgE that leads
to activation of phospholipase C, generating IP3 that subse-
quently causes a release of calcium from cytosolic stores and
thus triggers secretion (Kinet, 1999). The mast cells secrete a
variety of inflammatory mediators, including histamine,
from granules that contain many lysosomal markers (Grif-
fiths, 1996). The presence of lysosomal markers in the secre-
tory granules of mast cells and other secretory cells of he-
mopoietic lineage (such as basophils, cytotoxic T cells,
natural killer cells, neutrophils, eosinophils, and macro-
phages) has led to the suggestion that these secretory gran-
ules are not derived from the classical secretory pathway,
but are derived from the lysosomal pathway (Stinchcombe
and Griffiths, 2001).
Permeabilization of secretory cells with detergents such as
digitonin, bacterial toxins such as Streptolysin-O (SLO) or by
mechanical disruption allows exocytosis to be triggered by
the addition of buffered calcium solutions, bypassing the
need for activation of a triggering receptor and associated
signal transduction events (Gomperts and Tatham, 1992). In
mast cells an absolute requirement for guanine nucleotides
has been reported, unlike neuroendocrine cells where gua-
nine nucleotides appear to have a modulatory role (Lillie
and Gomperts, 1992). This has led to the identification of a
number of GTP binding proteins including Gi3 (Aridor et
al., 1993),  subunits (Pinxteren et al., 1998), rac (O’Sullivan
et al., 1996), rho (Price et al., 1995), and cdc42 (Brown et al.,
1998), which all appear to regulate secretion in mast cells.
Although the final fusion event is mediated by the SNAP/
NSF/SNARE system in both mast cells (Guo et al., 1998;
Paumet et al., 2000, Baram et al., 2001), neurons and neuroen-
docrine cells (Jahn and Su¨dhof, 1999), it is possible that the
origin of these secretory granules accounts for the differ-
ences observed in the regulation of secretion in these cells
when compared with the more commonly studied neuroen-
docrine systems.
After permeabilization secretory cells leak cytosolic pro-
teins, leading to a progressive loss of responsiveness to Ca2
and nucleotides. This loss of response or rundown can be
slowed by the provision of exogenous cytosol and has been
used as the basis of a bioassay in mast cells (O’Sullivan et al.,
1996), chromaffin cells (Morgan and Burgoyne, 1992), and
PC12 and GH3 cells (Walent et al., 1992) to purify cytosolic
proteins that regulate secretion from these cells. We have
previously shown that a rac/RhoGDI complex isolated from
bovine brain cytosol partially restores secretory responsive-
ness in Streptolysin-O–permeabilized mast cells (O’Sullivan
Article published online ahead of print. Mol. Biol. Cell 10.1091/
mbc.E01–10–0094. Article and publication date are at www.molbi-
olcell.org/cgi/doi/10.1091/mbc.E01–10–0094.
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et al., 1996). A number of other activities were partially
purified during the purification of the rac/rhoGDI complex.
Here we report the full purification and identification of a
second brain cytosolic protein, Secernin 1 (Secern is an ar-
chaic English term for secrete), which is also capable of
regulating exocytosis in permeabilized mast cells.
MATERIALS AND METHODS
Frozen bovine brains were purchased from First Link UK (Brierley
Hill, West Midlands, UK). Male Sprague Dawley rats were pur-
chased from B&K Universal Ltd. (Hull, UK). GTP--S and bovine
serum albumin was purchased from Roche Diagnostics Ltd. (Lewes,
East Sussex, UK). Streptolysin-O (Murex formulation) was pur-
chased from Corgenix Biotech Limited (Temple Hill, Dartford, Kent,
UK). Ceramic hydroxyapatite column was purchased from Bio-Rad
(Hemel Hempstead, UK), and all other chromatography columns
were purchased from Amersham-Pharmacia (Amersham, UK).
Donkey anti-rabbit horseradish peroxidase (HRP) antibody was
purchased from Amersham-Pharmacia. The GATEWAY cloning
system and ThermalAce DNA polymerase kit was obtained from
Invitrogen, Life Technologies (Paisley, UK). The human cDNA
clone of the gene KIAA0193 was obtained from the Kazusa DNA
Research Institute (Kisararazu, Chiba, Japan) and inserted in the
pBluescript SK vector. All other chemicals used were of the highest
quality available from standard commercial sources.
Experimental Procedures
Secretion Measurements. Cells were obtained by peritoneal lavage
of male Sprague Dawley rats (300 g), and mast cells were purified
to 98% purity by centrifugation through Percoll as previously
described (Tatham and Gomperts, 1990). Cells, suspended in assay
buffer (137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 20 mM piperazine-
N,N-bis(2-ethanesulfonic acid), pH 6.8) supplemented with 1
mg/ml bovine serum albumin (BSA) were incubated with metabolic
inhibitors (0.6 mM 2-deoxyglucose and 10 M antimycin A) for 5
min at 37°C and then cooled to ice temperature and added to SLO
(1.6 IU/ml) in the presence of 0.1 mM EGTA. After 5 min, cells were
washed free of unbound SLO and contaminating impurities (Larbi
and Gomperts, 1996) by dilution and centrifugation at 4°C. Perme-
abilization and hence rundown of the secretory response was initi-
ated by transferring the cells to prewarmed (37°C) assay buffer
containing 1 mg/ml BSA, 0.3 mM Ca/EGTA buffer (10 nM Ca2),
100 M MgATP, and proteins under test in 96-well microtiter
plates. After allowing predetermined times for rundown (generally
between 5 and 20 min), the cells were stimulated to secrete by
addition of solutions containing Ca/EGTA buffers formulated to
regulate 10 M Ca2(or 100 nM Ca2 for controls) to a final con-
centration of 3 mM and GTP--S to a final concentration of 100 M
(or zero for controls) with sufficient MgATP to maintain the con-
centration at 100 M. After 20 min the reactions were quenched by
addition of ice-cold buffer supplemented with EGTA (10 mM), and
the cells were sedimented by centrifugation. The supernatants were
sampled for measurement of secreted hexosaminidase as previously
described (Tatham and Gomperts, 1990).
Calcium/EGTA buffers were prepared by mixing solutions of
EGTA and end-point–titrated CaEGTA made up at identical con-
centrations and adjusted to pH 6.8, according to a computer pro-
gram, as previously described (Tatham and Gomperts, 1990).
Secretion is expressed as the percent of total cellular hexosamini-
dase released, calibrated by reference to appropriate reagent blanks
and the total cell content released by 0.1% Triton X-100. Stimulated
secretion is calculated as the difference in the amount of hex-
osaminidase released in response to 100 nM Ca2 or 10 M Ca2 
100 M GTPS. All determinations were carried out in quadrupli-
cate unless otherwise stated.
Purification of Secernin 1. All chromatography was carried out on a
Bio-Rad Biologic liquid chromatography system at 4°C. Frozen bo-
vine brains, 500 g, were thawed at 4°C before homogenization in a
Waring blender in 1 liter homogenization buffer (137 mM NaCl, 2.3
mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 M Pepstatin, 1 M Leu-
peptin, 0.1 mM PMSF, 0.02% NaN3, 20 mM Pipes, pH 6.8). The
homogenate was then centrifuged for 10 h at 10,000  g at 4°C in a
fixed angle rotor. This cytosol extract was subjected to ammonium
sulfate precipitation and an active fraction between 60 and 90%
(NH4)2SO4 was resuspended in 40 ml homogenization buffer. The
active material was subjected to chromatography on Octyl Sepha-
rose FF as previously described (O’Sullivan et al., 1996), and the
active fractions were combined. All column fractions under test
were buffer exchanged into assay buffer using NAP-5 columns
before assay.
DEAE Chromatography. The active fractions from the Octyl Sepha-
rose column were combined and desalted into buffer A (20 mM
diethanolamine, 0.02% NaN3, pH 8.7) in aliquots of 5 ml on a
HiPrep 26/10 desalting column (Pharmacia). The desalted material
was loaded, using on line dilution via the pump, at 20% protein
with 80% buffer A, onto a DEAE Sepharose column (XK26/50, 100
ml, Pharmacia) that had been equilibrated with buffer A. The col-
umn was then washed with 36 ml 20 mM diethanolamine, pH 8.7,
before elution with a linear gradient of 0–40% buffer B (1 M NaCl,
20 mM diethanolamine, 0.02% NaN3, pH 8.7) over 372 ml followed
by a final elution in 100% buffer B over 120 ml. The column was run
at 5 ml/min, and 8-ml fractions were collected. The fractions were
assayed for activity, and the active fractions (45–52) on the third
peak were combined.
Hydroxyapatite Chromatography. Active fractions (45–52) from the
third peak of the DEAE chromatography were concentrated to 5 ml
on a 50-ml Amicon pressure concentrator (43-mm YM10 membrane)
and then desalted into buffer C (50 mM MES, 0.02% NaN3, pH 6.0)
on a HiPrep 26/10 desalting column. This was then loaded onto a
ceramic hydroxyapatite column (Econo-Pac CHT-II, 1 ml, Bio-Rad)
preequilibrated with buffer C. The column was then washed with 2
ml buffer C before elution with a linear gradient of 0–100% buffer D
(500 mM NaCl, 50 mM MES, 0.02% NaN3, pH 6.0) over 16 ml. The
column was then washed with an additional 2 ml buffer D, before
elution with a 0–100% linear gradient of buffer E (500 mM KH2PO4,
50 mM MES, 0.02% NaN3, pH 6.0) over 16 ml and finally washed
with an additional 4 ml of buffer E. The column was run at 1
ml/min, and 1-ml fractions were collected. The fractions were as-
sayed for activity, and the active fractions (35–38) in the second peak
were combined.
Phenyl Superose Chromatography.The combined fractions from
peak 2 of the hydroxyapatite column were diluted with 3.4 M
(NH4)2SO4, buffered with 50 mM NaH2PO4, 0.02% NaN3, pH 7.5, to
produce a final concentration of 2 M (NH4)2SO4. The protein was
then applied to a Phenyl Superose column (Pharmacia, HR5/5, 1
ml) equilibrated in buffer F ((NH4)2SO4, 50 mM NaH2PO4, 0.02%
NaN3, pH 7.5) and the column washed with 5 ml 100% buffer F
before eluting with a 30–80% gradient of buffer G (50 mM
NaH2PO4, 0.02% NaN3, pH 7.5) over 30 ml, followed by a final 5 ml
of 100% buffer G. The column was run at 0.4 ml/min, and 1-ml
fractions were collected.
Superose 12 Chromatography. Active fractions from the Phenyl
Superose (21–23) were concentrated to 240 l on a 10K Microsep
centrifugal concentrator (Filtron, Northborough, MA) at 4°C and
injected onto a Superose 12 column (Pharmacia, HR10/30, 24 ml)
equilibrated in homogenization buffer. The column was run at
0.2/ml min, and 0.5-ml fractions were collected. The active fractions
were combined and concentrated before use in secretion experi-
ments.
Leakage of Secernin. Purified mast cells were treated with diiso-
propyl fluorophosphate (2 mM) for 10 min at 4°C. The cells were
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treated with SLO at ice temperature as described above, resus-
pended at 1  106cells/ml, and then permeabilized by bringing
the temperature to 37°C. Samples of cells, 100 l, were removed
at intervals and sedimented by centrifugation at 14,000  g, and
the supernatants were harvested. Ice-cold acetone was added to
the supernatants to a final concentration of 80%, and the mixture
was maintained at 20°C for 2 h after which the aggregated
proteins were sedimented by centrifugation at 14,000  g. These
were taken up in Laemmli sample buffer and separated on 12%
SDS-polyacrylamide gels. Proteins were transferred to nitrocel-
lulose using a wet blot method and probed for Secernin using the
polyclonal anti-Secernin antibodies, SK1147 and SK1148, at a
dilution of 1:4000. Antibody binding was detected using a don-
key anti-rabbit HRP-linked secondary antibody at 1:2000 dilution
and an ECL detection kit.
Plasmid Construction. Oligonucleotide primers for the amplifica-
tion of the KIAA0193 gene were designed with attB1 or attB2 sites
for the insertion into the GATEWAY donor vector pDONR201 (Life
Technologies) by homologous recombination. Primers with the fol-
lowing sequences were synthesized by MWG, Inc.: KIAA0193 (for-
ward), 5- GGGGACAAGTTTGTACAAAAAAGCAGGCTTCG A A
GGAGATAGAACCATGATAAGCAGACCCGCCTGGCTCT-3; KIAA
0193 (reverse), 5-GGGGACCACTTTGTACAAGAAAGCTGGGTC-
CTATCACTTAAAGAACTTAATCTCCGTG-3. The primers were
used to generate the attB PCR product using a ThermalAce DNA
polymerase kit (Invitrogen) from the pBluescript SK vector con-
taining KIAA0193. The PCR products were cloned into pDONR201,
and the resulting plasmid pENTR KIAA0193 were used to transfer
the gene sequences into pDEST15 (N terminal GST fusion) or pD-
EST17 (N terminal His fusion) via homologous recombination. The
corresponding plasmids, pEXP15 KIAA0193 and pEXP17
KIAA0193, were used for overexpression of the fusion proteins in
Escherichia coli BL21-SI.
Recombinant Protein Purification. Cells carrying either pEXP15
KIAA0193 or pEXP17 KIAA0193 were grown overnight in LB broth
without NaCl in the presence of 100 g/ml ampicillin at 30°C. The
cells were then diluted 1 in 10 in prewarmed LB broth without
NaCl, in the presence of 100 g/ml ampicillin at 30°C, and grown
to an optical density of 0.6 at 600 nm. Protein expression was
induced by the addition of NaCl to 0.3 M, and the cells were grown
for a further 3 h. Cells were harvested by centrifugation, and inclu-
sion bodies were purified by the method of Marston et al. (1984).
Affinity Purification of Antibody SK1147. Inclusion bodies of the
recombinant GST-tagged KIAA 0193 (human Secernin 1) were sol-
ubilized in SDS-sample buffer and separated on 10% SDS-PAGE.
After blotting onto nitrocellulose paper the recombinant protein
was visualized with Ponceau S staining, and the bands were ex-
cised. The antibody SK1148 was affinity purified against this protein
by the method of Smith and Fisher (1984). The antibody was dia-
lyzed overnight against homogenization buffer before use in neu-
tralization experiments.
Immunoneutralization of Secernin. Polyclonal anti-Secernin anti-
body SK1147 or preimmune serum was diluted 1:50 into assay
buffer and added an equal volume of either purified 60 g/ml
Secernin or 6 mg/ml freshly prepared rat brain cytosol in assay
buffer. The antibody and proteins were incubated at 4°C for 30 min
before addition to permeabilized mast cells at a final concentration
Figure 1. Purification of secernin. (A) DEAE chromatography. Ac-
tive fractions from Octyl Sepharose were desalted and loaded onto
a DEAE Sepharose column, the activity was eluted with a rising
gradient of NaCl. (B) Hydroxyapatite chromatography. Pooled frac-
tions from peak 3 on the DEAE column were desalted and applied
to a ceramic hydroxyapatite column. The activity was initially
eluted with a rising gradient of NaCl followed by a second gradient
of KH2PO4. (C) Phenyl Superose chromatography. Pooled fractions
from peak 2 on the hydroxyapatite column were adjusted to 2 M
(NH4)2SO4 and applied to a Phenyl Superose column. The activity
was eluted with a falling gradient of (NH4)2SO4. All column activ-
ities were assayed for protein concentration and stimulated secre-
tion as described in the MATERIALS AND METHODS. Data shown
are mean SEM (n 4); similar results were obtained on at least 10
occasions. Some error bars are smaller than symbols used.
Table 1. Purification of secernin 1
Step
Total
protein
(mg)
Specific activity
(% Stimulation/
mg protein)a
Fold
enrichment
Ammonium sulphate pellet 1550 ND —
Octyl Sepharose pool 228 0.097 1
DEAE peak 3 pool 1.45 5.10 52.6
Hydroxyapatite peak 2 pool 0.307 19.87 205
Phenyl Superose pool 0.034 208.82 2,153
Superose 12 pool 0.0044 1454.5 14,995
a Specific activity of each of the pooled peaks is calculated as aver-
age increase in stimulated release per mg protein for a typical
purification.
G. Way et al.
Molecular Biology of the Cell3346
of 10 g/ml Secernin and 1 mg/ml cytosol as described above.
Varying concentrations of affinity-purified SK1147 was incubated
with 3 mg/ml cytosol in the presence or absence of 5 mg/ml
inclusion body containing recombinant human Secernin 1-His fu-
sion protein. After incubation for 60 min at 4°C, the cytosol was
centrifuged at 14,000  g to remove the inclusion body before
addition to permeabilized mast cells at a final concentration of 1
mg/ml cytosol and antibody as indicated.
Protein Assay. Protein concentration was assayed by the method of
Bradford (1976) using BSA as a standard.
Protein Analysis. Purity of protein samples was assessed by elec-
trophoretic separation on 12% SDS-polyacrylamide gels (Laemmli,
1970) and detection by silver staining (Morrissey, 1981).
Production of Antisera. Two polyclonal rabbit antisera (SK1147 and
SK1148) were raised against purified Secernin 1 by Abcam Ltd.
(Cambridge, UK), using a 30-g initial injection followed by three
booster injections of 30 g.
Mass Spectrometric Analysis. p50 was alkylated with iodoacet-
amide in sample buffer (Novex, Encinitas, CA) and run on a 4–12%
SDS-PAGE gel with a MOPS running buffer system (Novex). The gel
was stained with Sypro Orange (Molecular Probes, Eugene, OR),
and the p50 band was excised and digested with 12.5 g/ml mod-
ified trypsin (Roche) in 20 mM NH4CO3. A proportion of the sample
was analyzed by MALDI-TOF MS, and the tryptic peptide ions were
searched against NCBI and Swiss Prot databases using the MS-FIT
search algorithm from Protein Prospector (UCSF, San Francisco,
CA).
The remainder of the sample was chromatographed on a 150 
0.075-mm Pepmap C18 capillary column coupled to an LC Packings
Ultima HPLC system (Dionex, Camberley, UK). The column was
equilibrated with 2% acetonitrile/0.1% formic acid in water at 0.2
l/min, and developed with a gradient of acetonitrile/0.1% formic
acid. The outlet of the column was connected to a Micromass
Q-TOF2 mass spectrometer, equipped with a nanoflow source, and
peptide ions were automatically submitted for ms/ms fragmenta-
tion. Spectra from ms/ms experiments were interpreted, and the
sequences were searched against NCBI nr and dbEST databases
using the BLAST search algorithm. Spectral data was also searched
against the same databases using the Sonar ms/ms search algorithm
(http://service.proteometrics.com/prowl/sonar.html).
RESULTS
Bovine brain cytosol was prepared and fractionated by am-
monium sulfate precipitation followed by Octyl Sepharose
chromatography as previously described (O’Sullivan et al.,
1996). The purification of Secernin 1 described in MATERI-
ALS AND METHODS is summarized in Table 1. Activity
from cytosol prepared from frozen bovine brains is only
detectable after the Octyl Sepharose column, unlike cytosol
from freshly isolated rat brains (O’Sullivan et al., 1996). The
purification is therefore calculated from the pooled activity
from this column. Figure 1A shows that the activity eluted
Figure 2. Superose 12 chromatography. (A) Active
fractions from the Phenyl Superose column were
concentrated and loaded onto a superose 12 gel fil-
tration column and assayed for protein concentra-
tion and stimulated secretion as described in the
MATERIALS AND METHODS. Data shown are
mean  SEM (n  4); similar results were obtained
on at least 10 occasions. Some error bars are smaller
than symbols used. (B) Active fractions were ana-
lyzed by silver-stained 12% SDS-PAGE.
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from the Octyl Sepharose can be separated by a DEAE
Sepharose column into three distinct peaks of activity by a
gradient of NaCl. Peak 1 was found to contain the previ-
ously purified rac and rhoGDI, as assessed by Western
blotting, so further purification of this peak was not under-
taken. Peak 3 appeared to have the highest activity and was
therefore subjected to further purification.
The combined fractions of peak 3 from the DEAE column
were applied to a hydroxyapatite column and eluted with a
rising gradient of NaCl, followed by a rising gradient of
KH2PO4 as shown in Figure 1B. A small peak of activity
elutes with NaCl and a larger second activity elutes with
KH2PO4. This second activity peak was pooled, applied to a
Phenyl Superose column and eluted by a decreasing gradi-
Figure 3. Identification of p50
by MALDI-TOF and Q-TOF mass
spectrometry. A tryptic digest of
p50 excised from a SDS-PAGE gel
was subjected either to finger-
print analysis by MALDI-TOF
mass spectrometry or reverse-
phase HPLC and online Q-TOF
ms/ms fragmentation. (A)
MALDI-TOF mass spectrum an-
notated with the sequence and
molecular mass (m/z) of identi-
fied peptides (highlighted in
gray). Peptides whose sequence
was deduced by Q-TOF fragmen-
tation analysis are boxed. (B) The
predicted polypeptide sequence
encoded by mouse cDNA
AK012765. Peptide sequences
identified by MALDI fingerprint
analysis above are highlighted in
gray. Peptides whose sequence
was deduced by MS/MS frag-
mentation (in bold font) are
aligned.  indicates a match, 
indicates a conserved substitu-
tion, and (.) indicates a mismatch
between the sequences. The out-
lined area () represents the pre-
dicted coiled-coil region.
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ent of (NH4)2SO4 as shown in Figure 1C. Fractions from the
column were then subjected to SDS-PAGE analysis, a single
protein of 50 kDa appears to correlate with the activity from
the phenyl superose column. To confirm the correlation, the
pooled fractions from the Phenyl Superose column were
concentrated and applied to a Superose 12 gel filtration
column. The fractions were assayed for their ability to retard
the rundown of exocytosis in mast cells and subjected to
SDS-PAGE, and again a single 50-kDa protein was found to
correlate with the activity, as shown in Figure 2.
To identify the 50-kDa protein, the purified material was
subjected to SDS-PAGE and in-gel trypsinization. The pep-
tide mixture was recovered and subjected to MALDI-TOF
mass spectrometry, and the resultant mass fingerprint used
to interrogate sequence databases. This analysis identified
p50 as a protein corresponding to a previously cloned
mouse cDNA (GenBank accession no. AK012765) of un-
Figure 4. Secernin 1 dose response. Mast cells permeabilized with
SLO in the presence of varying concentrations of Secernin 1. After 15
min the cells were stimulated by addition of solutions containing
EGTA buffered to 10 M Ca2 plus GTPS (final concentration, 100
M) or 100 nM Ca2. After a further 20-min incubation, the cells
were sedimented by centrifugation, and the supernatants were sam-
pled for analysis of secreted hexosaminidase. Stimulated secretion is
calculated as the difference in the amount of hexosaminidase re-
leased in response to either 100 nM Ca2 or 10 M Ca2  100 M
GTPS. Data shown are mean  SEM (n  4); similar results were
obtained on four occasions. Some error bars are smaller than sym-
bols used.
Figure 5. Effect of Secernin on rundown of secretory response.
Mast cells permeabilized with SLO in the presence (F) and absence
(E) of Secernin 1 at a final concentration of 3.5 g/ml. At times
indicated, samples were removed and stimulated by transfer to
solutions containing EGTA buffered to 10 M Ca2 plus GTPS
(final concentration, 100 M) or 100 nM Ca2. After a further 20-min
incubation, the cells were sedimented by centrifugation, and the
supernatants were sampled for analysis of secreted hexosaminidase.
Stimulated secretion is the difference in the amount of hexosamini-
dase released in response to either 100 nM Ca2 or 10 M Ca2 
100 M GTPS. Data shown are mean SEM (n 4); similar results
were obtained on four occasions. Some error bars are smaller than
symbols used.
Figure 6. Presence of Secernin in mast cell cytosol. (A) Western
blot of intact mast cells. After transfer to nitrocellulose membranes,
the proteins were detected by probing with the rabbit polyclonal
antibody SK1147 and a donkey anti-rabbit HRP secondary antibody
visualized by ECL. (B) The permeabilized mast cells were sampled
at the times indicated and rapidly sedimented. Proteins present in
the supernatants were precipitated and Western blotted. Proteins
were detected with antibody SK1147.
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known function (Figure 3). To confirm the identity of p50,
the balance of the peptide mixture was chromatographed
by reverse-phase HPLC, and individual peptides were
delivered to an online Q-TOF mass spectrometer for
ms/ms fragmentation and consequent peptide sequence
identification. A total of seven peptides were sequenced
(Figure 3B, bold). Of these, three corresponded to pep-
tides previously identified by mass fingerprint, and each
showed sequence identity with the putative protein en-
coded by AK012765. One peptide, not identified in the
initial mass fingerprint also was identical to the mouse
sequence, whereas three additional peptides were closely
related, showing 75% homology with it. We conclude
that p50 is a novel protein, which we have named Secer-
nin 1, which is encoded by the bovine orthologue of
mouse AK012765.
Figure 4 shows the effect of increasing concentrations of
purified Secernin 1 on the secretion of hexosaminidase from
permeabilized mast cells. The optimal concentration of Se-
cernin 1 is 7.1 0.9 g/ml with an EC50 of 2.21 0.2 g/ml
(mean SEM, n 4), which is comparable to other proteins
previously demonstrated to regulate secretion in these cells
(O’Sullivan et al., 1996; Pinxteren et al., 2001). This effect on
secretion is unlikely to be due to nonspecific protein effects
because neither boiled Secernin 1 at 10 g/ml nor BSA up to
1 mg/ml had any effect on secretion from these cells
(O’Sullivan, unpublished observations). Figure 5 shows the
effect of the protein at various times of rundown, the protein
initially has no effect, but as the cytosol leaks from the cells,
there is an increasing effect, which in turn declines as other
proteins leak from the cell. However, Secernin 1 is incapable
of completely preventing rundown.
To determine that the protein is present in mast cells, a
rabbit polyclonal antibody SK1147 was generated against
the purified protein. Figure 6A shows a Western blot of whole
mast cells demonstrating a single immunoreactive band at 50
kDa; a similar result was obtained with a second polyclonal
antibody SK1148. The results shown in Figure 5 are consistent
with a model in which Secernin 1 leaks slowly from the per-
Figure 7. Inhibition of Secernin in cytosol by anti-Secernin anti-
body. (A) Mast cells permeabilized with SLO in the presence of 10
g/ml purified Secernin 1 or 1 mg/ml rat brain cytosol, which had
been immunoneutralized with SK1147 antisera, preimmune serum,
or sham neutralized with buffer. After 15 min the cells were stim-
ulated by addition of solutions containing EGTA buffered to 10 M
Ca2plus GTPS (final concentration, 100 M) or 100 nM Ca2After
a further 20 min incubation, the cells were sedimented by centrifu-
gation, and the supernatants were sampled for analysis of secreted
hexosaminidase. Stimulated secretion is the difference in the
amount of hexosaminidase released in response to either 100 nM
Ca2 or 10 M Ca2  100 M GTPS. Data shown are mean 
SEM (n  4); similar results were obtained on four occasions. (B)
Mast cells permeabilized with SLO in the presence or absence of 1
mg/ml rat brain cytosol that had been immunoneutralized varying
concentrations of affinity-purified SK1147 antisera, in the presence
and absence of inclusion bodies containing recombinant human
Sescernin 1. After 15 min the cells were stimulated by addition of
solutions containing EGTA buffered to 10 M Ca2plus GTPS
(final concentration, 100 M) or 100 nM Ca2. After a further 20-min
incubation, the cells were sedimented by centrifugation, and the
supernatants were sampled for analysis of secreted hexosaminidase.
Stimulated secretion is the difference in the amount of hexosamini-
dase released in response to either 100 nM Ca2 or 10 M Ca2 
100 M GTPS. Data shown are mean SEM (n 4); similar results
were obtained on four occasions.
Figure 8. Effect of Secernin on the time course of secretion. Mast
cells permeabilized with SLO in the presence (f) or absence () of
3 g/ml purified Secernin 1. After 15 min the cells were stimulated
by addition of solutions containing EGTA buffered to 10 M
Ca2plus GTPS (final concentration, 100 M). After a further 20-
min incubation, the cells were sedimented by centrifugation, and
the supernatants were sampled for analysis of secreted hexosamini-
dase. Data shown are mean  SEM (n  3); similar results were
obtained on four occasions. Some error bars are smaller than sym-
bols used. The inset figure shows the same data normalized to 100%
response for each of the conditions after 25 min secretion.
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meabilized cell and the exogenously added Secernin 1 replaces
the lost protein. To test this hypothesis, supernatants were
collected from cells permeabilized over increasing periods. The
supernatants were precipitated by acetone at20°C, separated
by SDS-PAGE, and analyzed by Western blot. Figure 6B shows
that the antibody detects an increasing amount of the 50-kDa
protein in the supernatants with time after permeabilization,
confirming that the protein is cytosolic and leaks from the cell
after permeabilization with a similar time course to the run-
down of the secretory response.
To confirm that that the effects of Secernin 1 were due to
the 50-kDa protein the anti-Secernin antibody, SK1147 was
used to immunoneutralize the purified protein. Figure 7A
shows that the antibody blocks the effect of the optimal dose
of Secernin 1, whereas same concentration of the preimmune
sera has no significant effect. This concentration of antibody
is also inhibits the effect of freshly prepared rat brain cytosol
by 50%, indicating that Secernin is responsible for a signif-
icant amount of the activity found in whole cytosol. To
confirm that this effect was due to the interaction of SK1147
with Secernin, the antibody was affinity purified against
recombinant human Secernin 1. Figure 7B demonstrates that
the affinity-purified antibody inhibits fresh rat brain cytosol
and that this inhibition can be blocked by inactive recombi-
nant human Secernin 1 in an inclusion body.
Two possible mechanisms for Secernin 1 to increase the
extent of secretion would be to increase either the rate of
secretion or to allow secretion to occur over a much longer
period. Figure 8 clearly demonstrates that the addition of Se-
cernin 1 to the cells during rundown, before stimulation, in-
creases the rate of secretion from the permeabilized mast cells.
If the data are normalized to the response at 25 min, as shown
in the inset to Figure 8, it becomes clear that although the rate
of secretion is increased by Secernin 1, the time course of the
secretory response is unaffected by the presence of Secernin 1.
We have previously shown that the sensitivity of the mast
cells to both Ca2 and GTPS declines as a consequence of the
rundown of the secretory response (Brown et al., 1998). There-
fore, we investigated the possibility that Secernin 1 not only
increased the rate and extent of secretion, but also had an effect
on the sensitivity of the mast cells to stimulation with both
Ca2 and GTPS. Figure 9A shows the effect of Secernin on the
GTPS sensitivity of cells in the presence of 0.1 and 10 M
Ca2. Under these rundown conditions, all concentrations of
GTPS in the presence of 0.1 M Ca2 are incapable of induc-
ing secretion, whether Secernin 1 is present or not. In the
presence of 10 M Ca2 Secernin 1 increases the extent of
secretion by the same amount, independent of the concentra-
tion of GTPS. Figure 9B clearly demonstrates that Secernin 1
partially restores the Ca2 sensitivity of the rundown mast
cells, with some Ca2-dependent secretion even occurring in
the absence of GTPS.
DISCUSSION
We have purified a novel cytosolic protein, termed Secernin
1, which regulates exocytosis in permeabilized rat peritoneal
mast cells. Database analysis reveals that fragments of Se-
cernin 1 identified by mass spectrometry show 93.5% iden-
tity and 95.7% homology with the predicted product of
mouse cDNA AK012765, which has a predicted MW of
46296, which is consistent with our estimated molecular
weight of 50 kDa from SDS-PAGE. Database searching in-
dicates that Secernin 1 is encoded by one of a small family of
related genes (Figure 10). The human genome contains three
Secernin genes (termed Secernins 1 through 3), which are
localized on chromosomes 7 (7p14.3-p14.1), 17 (17q21.3), and
2 (2p14-q14.3), respectively. Analysis of cDNAs correspond-
ing to human Secernin 2 indicates the existence of at least
two splice variants (2a and 2b), one of which generates a
protein containing a truncated C terminus. Comparison of
human and mouse Secernin 1 cDNAs suggests that the
former has a truncated N-terminus lacking60 amino acids.
However, it is also possible that this is a splice variant of a
larger protein, because inspection of the 5 noncoding region
of the existing cDNA as well as the genomic DNA sequence
indicates the presence of a putative exon, which is highly
Figure 9. (A and B) Effect of Secernin on the sensitivity of mast cell
secretion to Ca2 and GTPS. Mast cells permeabilized with SLO in
the presence (filled symbols) or absence (open symbols) of 3 g/ml
Secernin 1. After 15 min the cells were stimulated by addition of
solutions containing the following: (A) EGTA buffered to either 0.1
M (F, E) or 10 M Ca2(, ƒ) plus varying concentrations of
GTPS or (B) EGTA buffered to varying concentrations of Ca2 plus
a final concentration of either 0 (Œ, ‚) or 100 M GTPS (f, ).
After a further 20-min incubation, the cells were sedimented by
centrifugation, and the supernatants were sampled for analysis of
secreted hexosaminidase. Data shown are mean  SEM (n  4);
similar results were obtained on four occasions. Some error bars are
smaller than symbols used.
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homologous to the relevant 5 coding sequence of mouse
Secernin 1. We have also identified two partial cDNA se-
quences in the TIGR bovine gene index database. These
correspond to a bovine homologue of human Secernin 2a
(Figure 10). The mouse genes are ubiquitously expressed
(Kawai et al., 2001), which would imply some common role
in many cell types rather than a protein specifically involved
in mast cell exocytosis.
Figure 10. Identification of Secernin family members in
mammalian species. The protein sequence for mouse Se-
cernin 1 was used to interrogate the NCBI Human Ge-
nome and nonredundant databases using the BLAST
search program. Sequences were aligned using the PIMA
sequence alignment program and formatted using BOX-
SHADE. Amino acid identities are shown as black boxes.
Conservative changes are shown as shaded boxes. The
GenBank accession numbers for Secernins are as follows:
hsSES1, AAD15417; hsSes2a, XP_054038.1; hsSes2b,
XP_032208.1; hsSes3, XP_035198.1; mmSes1, AK012765;
mmSes3, AK014701; BtSes2a, TC 80787, Tc80786.
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The full-length sequence for Secernin 1 shows no signifi-
cant degree of homology with any protein known to be
involved in exocytosis, membrane fusion events, or intracel-
lular signaling. The protein contains no known domain
structures apart from a small 21 amino acid region between
358 and 378, which is predicted to form a coiled-coil domain
by the COILS program (Lupas et al., 1991). It is therefore
possible that the actions of the protein may be mediated by
a direct interaction with another protein.
Two rabbit polyclonal antibodies raised against purified
bovine Secernin 1 recognize a single immunoreactive
band at 50 kDa in mast cells, confirming the presence of
Secernin 1 in mast cells. After permeabilization this pro-
tein leaks from the mast cells and can be precipitated from
the supernatant, confirming that the protein is cytosolic.
Secernin 1 leaks from the cell at a rate similar to the
decrease in secretory response of the mast cells during
rundown, implying that the leakage of Secernin 1 is a
major cause of the loss of secretory response. Addition of
Secernin 1 to permeabilized cells followed by stimulation
within the first 5 min has no effect on secretion, demon-
strating a lack of effect of the protein until sufficient
Secernin 1 has leaked from the cells to impair secretion.
The data are consistent with the hypothesis that exog-
enously added Secernin 1 is replacing the endogenous
protein leaking from the permeabilized cells, thus enhanc-
ing the secretory response under these conditions. The
addition of Secernin 1 alone is not capable of blocking the
loss of secretory response but slows the rate of loss of
response.
When cells are permeabilized and incubated at 37°C be-
fore stimulation, there is a decline in sensitivity to both Ca2
and guanine nucleotide. Secernin 1 partially restores Ca2
sensitivity, but not sensitivity to guanine nucleotide. We
have shown that although Secernin 1 increases the extent of
secretion from mast cells, the time course of secretion re-
mains the same. If we assume that any granule that fuses
with the plasma membrane releases either all or a constant
proportion of its hexosaminidase, then the simplest expla-
nation of this data is that Secernin 1 causes the recruitment
of additional secretory granules to the site of exocytosis in a
calcium-dependent manner. Alternatively Secernin 1, in the
presence of calcium, may be acting to increase the granule
swelling, core expulsion and breakdown observed in fused
granules (Zimmerberg et al. 1987; Monck et al., 1991), thus
increasing the release of hexosaminidase from the cells.
The loss of the secretory response is due to a number of
protein factors, including Secernin 1, Rac/RhoGDI, and the
other partially purified activities shown in Figure 1, and it is
likely that the full reconstitution of the secretory response
will require a large number of different proteins. This is
confirmed by the finding that inhibition of Secernin in cy-
tosol by immunoneutralization blocks 50% of the recovery
of secretion, indicating that although Secernin is not the only
cytosolic component that regulates mast cell secretion, it
appears to be an important component of the response.
Cytosolic proteins that are capable of regulating exocyto-
sis in permeabilized cell assays appear to fall into four major
categories: 1) proteins that directly interact with the fusion
machinery, including -SNAP (Chamberlain et al., 1995); 2)
GTPases involved in intracellular signaling, such as Arf
(Fensome et al., 1996, Caumont et al., 1998), rac (O’Sullivan et
al., 1996), rho (Price et al., 1995), and cdc42 (Brown et al.,
1998); 3) proteins involved in other intracellular signaling
pathways, such as PKC (Ozawa et al., 1993) and 14–3-3
(Morgan and Burgoyne, 1992); and 4) proteins involved in
the regulation of PIP2, such as PI kinases (Hay et al., 1995)
and PITP (Hay et al., 1995; Fensome et al., 1996; Pinxteren et
al., 2001). Our data clearly demonstrate that the cytosolic
protein Secernin 1 has a major role in the regulation of
exocytosis in mast cells, but further work is required to
determine which or if any of these pathways is the site of
action of Secernin 1.
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